노인당뇨병 치료의 최신지견

• 영문명: Recent Advances in the Treatment of Diabetes in the Elderly
• 발행기관: 대한임상노인학회
• 저자명: 박하경(Ha-Kyoung Park) 김헌성(Hun-Sung Kim)
• 간행물 정보: 『대한임상노인학회지』제25권 제3호, 129~134쪽, 전체 6쪽
• 주제분류: 의약학 > 기타의약학
• 파일형태: PDF
• 발행일자: 2024.12.31

국문 초록

As the elderly population increases, the prevalence of diabetes among individuals aged ≥65 years is steadily increasing. Therefore, individualized treatment strategies and methods for blood glucose management in elderly patients with diabetes mellitus should be established. Since symptoms related to blood glucose levels significantly differ among elderly patients, their physical and mental functional status, social conditions, and degree of frailty should be assessed comprehensively. Moreover, personalized treatment goals should be set according to their “life expectancy”, “current health status”, and “degree of frailty.” In selecting medications for diabetes, it is essential to consider the drug efficacy, understand the side effects and drug interactions according to each mechanism, and select an appropriate drug based on individualized treatment goals that fit the patient’s living environment and overall health status. Elderly patients at a high risk of hypoglycemia should set a flexible treatment target for blood glucose levels and continuously monitor the effects of medications and metabolic functions, considering cardiovascular risk factors and renal function status. Additionally, the occurrence of hypoglycemia should be monitored to manage blood glucose levels stably.

목차

서 론

본 론

결 론

FUNDING

CONFLICT OF INTEREST

REFERENCES

키워드

Diabetes mellitus Elderly Frailty Hypoglycemia

참고문헌

• Diabetes Care
• Int J Pure Appl Biosci
• Nat Rev Endocrinol
• Diabetes Spectr
• Front Endocrinol (Lausanne)
• J Phys Educ Sport
• J Am Med Dir Assoc
• PANMUNEDU
• Korean Diabetes Association
• J Korean Med Assoc
• Diabetes Spectr
• J Korean Diabetes
• Diabetes Metab J
• J Osteopath Med
• N Engl J Med
• N Engl J Med
• N Engl J Med
• Curr Diab Rep
• Annu Rev Physiol
• World J Pharm Res
• Lancet Diabetes Endocrinol
• Curr Drug Saf
• Diabetes Metab
• JAMA
• Diabetes Care
• Antioxidants (Basel)
• Cell Metab
• PANMUNEDU
• The Korean Society of Nephrology
• Korean Diabetes Association
• Front Endocrinol (Lausanne)
• J Clin Pharm Ther
• Diabetes Metab Syndr
• Diabetes Metab J
• Medicina (Kaunas)
• Osteoporos Int
• Expert Opin Pharmacother
• J Korean Diabetes
• Korean Diabetes Association
• Clin Sci (Lond)
• Postgrad Med
• Diabetes Care
• PANMUNEDU
• Korean Diabetes Association